Kromek Group plc (AIM: KMK), the County Durham-based detection technology company, has announced a £2.5m order from the UK Ministry of Defence for the supply of nuclear radiation detectors. The contract covers the Group's D5 RIID, a wearable, high-performance radiation detection device, and is scheduled for delivery within the financial year ending 30 April 2027. This marks the second order Kromek has received from the MOD for the D5 RIID, reinforcing an established supply relationship with a strategically significant defence customer.
Key Points
- Kromek Group plc (AIM: KMK) — global detection company focused on advanced imaging and CBRN detection markets
- £2.5m order received from the UK Ministry of Defence for nuclear radiation detectors
- Contract to be delivered in the current financial year ending 30 April 2027; this is the second MOD order for the D5 RIID
- Investors may be watching for further MOD contract wins and progress within the CBRN Detection division during the remainder of the financial year
Kromek's D5 RIID: The Wearable Radiation Detector at the Centre of the MOD Contract
The order is specifically for the D5 RIID, described in the announcement as a high-performance and versatile radiation detection device supplied in a wearable package. Kromek's CBRN detection products are built on advanced scintillation and solid-state readout technology, and are designed to protect critical infrastructure, personnel, and urban environments from radiological threats, including so-called dirty bombs. The D5 RIID sits within Kromek's portfolio of compact, handheld detectors sold primarily into the global homeland defence and security market, where the Group competes as a specialist technology provider.
Second MOD Award Signals Deepening UK Defence Relationship for Kromek
The announcement states this is Kromek's second order from the UK MOD for the D5 RIID, suggesting an ongoing and deepening supply relationship rather than a one-off procurement. CEO Arnab Basu noted in the announcement that the contract "reinforces our position as a trusted partner in national defence" and described the MOD as a "significant strategic customer." The repeat nature of the order may be of interest to investors assessing the durability of Kromek's defence revenue base, though the terms of any longer-term framework or future procurement pipeline were not disclosed in the announcement.
£2.5m Contract Expected to Contribute to CBRN Division Revenue Before April 2027
Kromek confirmed the contract is to be delivered within the current financial year ending 30 April 2027, meaning the £2.5m order value is expected to be recognised during this period. The CEO's statement in the announcement characterised the award as making "an important contribution to our continued growth in the CBRN Detection division." Kromek operates manufacturing facilities in both the UK and the US, and is headquartered in County Durham. No further financial guidance, divisional revenue targets, or margin information were disclosed in connection with this specific contract.
Kromek's Broader CBRN and Advanced Imaging Business Context
Beyond defence contracts, Kromek operates across two principal segments: advanced imaging, which includes medical, security and industrial applications built on its cadmium zinc telluride (CZT) platform, and CBRN detection, which also encompasses bio-security solutions targeting airborne pathogen detection. The Group supplies detector components to OEM customers enabling identification of diseases such as cancer and Alzheimer's, as well as explosives detection in aviation settings. This diversified technology base means the MOD order represents one revenue stream within a broader commercial and defence-facing business model.



Please wait processing your request...